Advestra advised Banque Cantonale de Genève on its inaugural EUR-Bonds of EUR 500 million. The issuance Banque Cantonale de Genève debuted on the EUR-bonds market, issuing bonds in the aggregate prin
As of March 2025, Ferdinand Winter (pictured) has been appointed General Counsel of Ten23 health, a Swiss pharmaceutical contract development and manufacturing organization. Moving from Hansa Biopharma, Sweden, Ferdinand will be responsible for establishing and leading
CMS Switzerland advised Spanish hotel brand and lease management company Room Mate Hotels hotel on its acquisition – by way of a share deal – of the Geneva-based Hotel Marmont’s long leasehold. The context The 4-star
Niederer Kraft Frey (NKF) advised outpatient healthcare provider Affidea on the acquisition of Uroviva Group. Moreover, Advestra advised German Equity Partners IV, a fund managed by the independent German
Karen Hale (pictured) is the new Chief Legal and Compliance Officer for Novartis, effective April 14, 2025. Following the new appointment, Hale will continue to report to Vas Narasimhan, CEO of Novartis, and remain on the Executive
Lenz & Staehelin advised Vivalto Partners on Swiss tax matters in connection with its acquisition of Linnea, an international pharmaceutical manufacturer of botanical ingredients based in Switzerland. The context Headquartered in Paris, Vivalto Partners is
Walder Wyss advised MedComms Experts (MCE), a global provider of rare-disease-focused medical communications services, in connection with a strategic investment by The Brydon Group (Brydon). The company Headquartered in Zurich, MCE is a multidisciplinary medical
Bär & Karrer advised HAS Healthcare Advanced Synthesis and its sole shareholder in the acquisition of Chemholding due and its subsidiaries, including its main operative company Cerbios-Pharma. The company HAS Healthcare Advanced Synthesis is
Homburger advised New Zealand Local Government Funding Agency (LGFA) in connection with its debut issuance under its EMTN Programme, marking the the agency’s first issuance in CHF. UBS Investment Bank and BNP Paribas (Suisse) &
